Compare · NTCO vs PHH
NTCO vs PHH
Side-by-side comparison of Natura &Co Holding S.A. (NTCO) and Park Ha Biological Technology Co. Ltd. (PHH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NTCO and PHH operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- NTCO carries a market cap of $13.48B.
- PHH has hit the wire 1 time in the past 4 weeks while NTCO has been quiet.
- NTCO has more recent analyst coverage (2 ratings vs 0 for PHH).
- Company
- Natura &Co Holding S.A.
- Park Ha Biological Technology Co. Ltd.
- Price
- $6.55-2.67%
- $0.38-0.29%
- Market cap
- $13.48B
- -
- 1M return
- -
- -23.43%
- 1Y return
- -
- -53.60%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- 2024
- News (4w)
- 0
- 1
- Recent ratings
- 2
- 0
Natura &Co Holding S.A.
Natura &Co Holding S.A. develops, manufactures, distributes, and sells cosmetics, fragrances, and personal care products. The company offers products for women and men, including skin care products for face and body, hair care and treatment products, makeup, soaps, deodorants, shower, cosmetics, fragrances, bath, sunscreen, oral hygiene, and baby and child toiletries, as well as fashion jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, travel kits and packages, entertainment and leisure products, children's products, and nutritional products. It markets its products under the Natura, Aesop, Avon, and The Body Shop brands through signature and department stores, e-commerce, direct selling, franchises, third-party online resellers, amenity accounts, and physical multibrand retailers primarily in Asia, North America, South America, Europe, the Middle East, Africa, and Oceania. Natura &Co Holding S.A. was founded in 1969 and is headquartered in São Paulo, Brazil.
Latest NTCO
- Natura and Avon Integration in Latam Continuing to Drive Healthier Profitability
- Another quarter of improved margins driving turnaround on profitability at Natura &Co
- SEC Form SC 13G/A filed by Natura &Co Holding S.A. (Amendment)
- Natura &Co Board Authorizes Its Management To Assess Possible Separation Of Natura & Co Latam And Avon To Unlock Further Shareholder Value
- Natura &Co to explore possible separation of Natura &Co Latam and Avon into two independent listed companies
- SEC Form SC 13G filed by Natura &Co Holding S.A.
- SEC Form 25 filed by Natura &Co Holding S.A.
- Natura &Co Expects The NYSE To Suspend Trading In The ADSs On Or About 9 February 2024
- On January 18, Natura &Co Announced Intention To End Secondary Listing Of ADSs On The NYSE, While Maintaining Its Primary Listing Of Common Shares On The B3 Stock Exchange In São Paulo
- SEC Form 6-K filed by Natura &Co Holding S.A.
Latest PHH
- Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store, Launching a New Era of Brand Globalization
- Park Ha Biological Technology Co., Ltd. Announces Membership Application to Personal Care Products Council (PCPC), Aligning the Brand with International Standards and Marking a Strategic Milestone in its Expansion into Amazon North America
- Park Ha Biological Technology Co., Ltd. Announces Cooperation with Amazon to Support Its Entry into the North American Personal Care Sector and Accelerate the Implementation of Its Global Strategy
- Park Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry.
- Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering
- Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering
- Park Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group's wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its healthcare reach
- Park Ha Biological Technology Co., Ltd. Announces Closing of a US$2.45 Million Public Offering
- Park Ha Biological Technology Co., Ltd. Announces Pricing of US$2.45 Million Best-Efforts Follow-on Public Offering
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.